# MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

> **NCT01660997** · PHASE2 · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** MLN9708
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01660997
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-07-30
- **Primary completion:** 2014-03-11
- **Final completion:** 2014-03-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01660997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01660997, "MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01660997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*